PubTransformer

A site to transform Pubmed publications into these bibliographic reference formats: ADS, BibTeX, EndNote, ISI used by the Web of Knowledge, RIS, MEDLINE, Microsoft's Word 2007 XML.




PMID- 28739775
OWN - NLM
STAT- MEDLINE
DA  - 20170725
DCOM- 20170803
LR  - 20170803
IS  - 1791-7530 (Electronic)
IS  - 0250-7005 (Linking)
VI  - 37
IP  - 8
DP  - 2017 Aug
TI  - Effect of Interventional Therapy on the Expression of Survivin mRNA in Cervical
      Cancer.
PG  - 4707-4710
AB  - AIM: To examine the expression of survivin mRNA in cervical squamous cancer at
      different time points during interventional therapy in order to find the optimal 
      time point for continual treatment. PATIENTS AND METHODS: Fifty patients with
      stage IB2-IIB cervical squamous cancer receiving transarterial infusion
      chemotherapy and chemoembolization were included in the present study. The
      expression of survivin mRNA in cancer samples before and after interventional
      therapy (on days 7, 14 and 21) were examined by reverse transcription-polymerase 
      chain reaction. RESULTS: The expression of survivin mRNA in cancer samples before
      the interventional therapy was significantly higher than that of any time point
      after the interventional therapy (p<0.05). After treatment, the expression of
      survivin mRNA decreased until day 14. CONCLUSION: The expression of survivin mRNA
      was inhibited by the interventional therapy. It seems that day 14 after
      interventional treatment is the right time point for continuation of treatment.
CI  - Copyright(c) 2017, International Institute of Anticancer Research (Dr. George J. 
      Delinasios), All rights reserved.
FAU - Wang, Shao-Guang
AU  - Wang SG
AD  - Department of Gynecology, the Affiliated Yantai Yuhuangding Hospital of Qingdao
      University, Yantai, P.R. China [email protected]
FAU - Mu, Nan
AU  - Mu N
AD  - Department of Gynecology, the Affiliated Yantai Yuhuangding Hospital of Qingdao
      University, Yantai, P.R. China.
FAU - Sun, Hai-Yan
AU  - Sun HY
AD  - College of Medicine, Qingdao University, Qingdao, P.R. China.
LA  - eng
PT  - Journal Article
PL  - Greece
TA  - Anticancer Res
JT  - Anticancer research
JID - 8102988
RN  - 0 (BIRC5 protein, human)
RN  - 0 (Inhibitor of Apoptosis Proteins)
RN  - 0 (RNA, Messenger)
SB  - IM
MH  - Adult
MH  - Antineoplastic Combined Chemotherapy Protocols/therapeutic use
MH  - Carcinoma, Squamous Cell/diagnosis/genetics/therapy
MH  - Comorbidity
MH  - Female
MH  - *Gene Expression
MH  - Humans
MH  - Inhibitor of Apoptosis Proteins/*genetics
MH  - Middle Aged
MH  - Neoplasm Staging
MH  - RNA, Messenger/*genetics
MH  - Risk Factors
MH  - Uterine Cervical Neoplasms/diagnosis/*genetics/*therapy
OTO - NOTNLM
OT  - Cervical cancer
OT  - interventional therapy
OT  - survivin
EDAT- 2017/07/26 06:00
MHDA- 2017/08/05 06:00
CRDT- 2017/07/26 06:00
PHST- 2017/06/01 [received]
PHST- 2017/06/20 [revised]
PHST- 2017/06/22 [accepted]
AID - 37/8/4707 [pii]
PST - ppublish
SO  - Anticancer Res. 2017 Aug;37(8):4707-4710.